^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Cxbladder

    Company:
    Pacific Edge
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    Cxbladder is a suite of non-invasive genomic urine tests optimized for the risk stratification of urothelial cancer in patients presenting with microhematuria and those being monitored for recurrent disease. The tests help clinicians improve the overall patient experience, while prioritizing time and clinical resources to optimize practice workflow and improve efficiency.
    Cancer:
    Bladder Cancer
    Method:
    PCR
    Confirmatory trial(s)
    NCT02700659
    |
    Oncol Ther